Baba Farid Sugar Mills Limited (BAFS)
Pakistan Stock Exchange (PSX) · Pakistan · prices in PKR · close of 27 Oct 2026
Key indicators
| Last close | PKR 407.52 |
|---|---|
| 52-week range | 181.01 – 647.00 |
| Return, 1 month / 3 months | −5.2% / −18.0% |
| Return, 1 year / 3 years | +90.7% / +1,321.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 40 |
| Volatility (1 year) | 66.5% |
| Worst drawdown (1 year) | -42.0% |
| Average daily value traded | 0.54M PKR |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Baba Farid Sugar Mills Limited is a Lahore-based manufacturer and seller of sugar, and it also trades in the by-products that come out of the milling process, namely molasses and V.Filter cake. Sugar refining takes the juice pressed from cane and boils it down until crystals form, leaving behind a dark syrup, while the leftover cake serves as a further output of the plant.
On this site Baba Farid Sugar Mills Limited appears as a stock on the Pakistan Stock Exchange (PSX), code BAFS, with prices in Pakistani rupees (PKR). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Baba Farid Sugar Mills Limited (BAFS) trades on the Pakistan Stock Exchange (PSX) in Pakistan. It last closed at PKR 407.52 on 27 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 294 of 542 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 90.7% and over the last three months it fell 18.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Pakistan Stock Exchange (PSX)
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 18.6% | ||
| From 52-week high | -33.3% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -18.0% | ||
| 6-month return | 74.3% | ||
| 12-month return, skipping the last month | 101.0% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 66.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -42.0% | ||
| Liquidity | 24 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.54M PKR | ||
| Zero-volume days | 0.0% | ||
| Income | 3 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −7.2% |
|---|---|
| 1 month | −5.2% |
| 3 months | −18.0% |
| 6 months | +74.3% |
| 1 year | +90.7% |
| 3 years | +1,321.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 457.49 / 343.61 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 22.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Jan 2026 | PKR 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Pakistan Stock Exchange (PSX); it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.